Company Summary
Search
Home Page
 
Cotinga Pharmaceuticals Inc 
Listed Company 
Current   Past  
Fiscal Year EndCompany StatusExempt Flag
April 30TradingN
Board of Directors
NamePosition
Alison Silva  President
  Director of the Board
Bharatt Chowrira  Director of the Board
Bruno C. Maruzzo  Director of the Board
David Sanderson  Director of the Board
Douglas Stewart Alexander  Director of the Board
John Drake  Chairperson of the Board
John Yoo  Director of the Board
Incorporation Locations
Inc. DateExpiry DateCountryRegionDescription
13/Oct/2006  Canada Ontario Business Corporations Act 
Exchange Filing Office
Location
Toronto Regional Service Office
Business Type(s)
Primary/SecondaryBusiness TypeDetails
Primary  Biotechnology/Biopharmaceutical  (not available) 
Securities
SymbolSecurity NameMarketStatus
COTCotinga Pharmaceuticals IncTSX VentureTRADING
Name HistoryFromTo
Cotinga Pharmaceuticals Inc10/Jan/2018Present
Company Facts Reconciliation
SubjectDate Returned
Spring 2015 CFR Not Received
Associations
Auditing Firm:  KPMG LLP
Investor Relations:  Trevor Heisler
Lawyer:  Don Bryant
Law Firm:  McKenzie Lake Lawyers LLP
Transfer Agent:  Computershare Investor Services Inc.
Latest Information
TypeDateTitle
News Releases  24/May/2018  NEWS RELEASE - FDA CLEARANCE OF SIGNIFICANT PROTOCOL CHANGES FO[MARKET NEWS]
    NEWS RELEASE - CLOSES $2.0M PRIVATE PLACEMENT[MARKET NEWS]
    NEWS RELEASE - FISCAL 2018 THIRD QUARTER FINANCIAL AND OPERATIN[MARKET NEWS]
Bulletins  15/May/2018  PP-B
Meetings and Public Filings  Information on financial statements, public filings and corporate meetings for all Canadian public companies can be found at www.sedar.com
Property Locations
(not available)

* Historical Data